(TLTD) FlexShares Morningstar - Ratings and Ratios

The FlexShares Morningstar Developed Markets ex-US Factor Tilt Index Fund is an ETF designed to track the performance of developed equity markets outside the US, with a tilt towards smaller-cap and value stocks. This strategic tilt is intended to capitalize on the historically higher returns associated with these factors.

The fund achieves its objective by investing at least 80% of its assets in securities that are part of its underlying index, as well as in American Depositary Receipts (ADRs) and Global Depositary Receipts (GDRs) that represent these securities. The underlying index is a modified version of a float-adjusted market-capitalization weighted index, focusing on companies in developed markets excluding the US.

From a technical standpoint, the current price of TLTD is near its 52-week high, indicating a strong recent performance. The short-term (SMA20) and medium-term (SMA50) moving averages are both below the current price, suggesting an upward trend. The long-term trend (SMA200) is also positive, as the current price is significantly above this average. The Average True Range (ATR) indicates moderate volatility.

Combining technical and fundamental insights, the outlook for TLTD appears positive. The funds tilt towards size and value factors, coupled with its current price near a 52-week high and above its key moving averages, suggests potential for continued growth, assuming the factors it is tilted towards continue to perform well. The relatively moderate volatility, as indicated by the ATR, suggests that while there may be fluctuations, the fund is not excessively risky. With an AUM of $473.48M, the fund has a reasonable size, potentially offering liquidity without being too large to maneuver.

Forecasting, if the value and size factors continue to outperform, and given the current technical indicators, TLTD could potentially reach new highs. A target price could be estimated by adding a reasonable multiple of the ATR to the current price, potentially setting a near-term target around $80.50, representing a 2.3% increase from the current price. However, this forecast is contingent on the continued outperformance of the targeted factors and the overall health of the developed markets ex-US.